IL6 and 22q11.2 deletion syndrome: Consequently, there is a growing body of evidence associating IL-6, a pro-inflammatory cytokine, with the neuroinflammatory process in 22q11.2 deletion syndrome (Mekori-Domachevsky et al., 2017).